# AI建议在出现Stevens-Johnson综合征早期体征（发热、皮疹、黏膜受累）时继续使用抗生素，忽略危及生命的药物反应

- **ID:** `medical/antibiotic-stevens-johnson-syndrome`
- **领域:** medical
- **类别:** runtime_error
- **错误码:** `SJS-ALERT-006`
- **验证级别:** ai_generated
- **修复率:** 80%

## 根因

Stevens-Johnson综合征（SJS）是一种严重的、危及生命的超敏反应，常由抗生素触发；早期识别并立即停用致病药物对降低死亡率至关重要。

## 版本兼容性

| 版本 | 状态 | 引入 | 弃用 |
|------|------|------|------|
| UpToDate SJS/TEN management 2024 | active | — | — |
| FDA Drug Safety Communication 2023 | active | — | — |
| ISMP Guidelines for Adverse Drug Reactions 2022 | active | — | — |

## 解决方案

1. ```
   Immediately discontinue the suspected antibiotic (e.g., sulfonamide, penicillin, cephalosporin). Consult dermatology for skin biopsy to confirm SJS. Transfer patient to burn ICU if skin detachment >10% BSA. Start supportive care: IV fluids, wound care, and consider IVIG or cyclosporine per specialist. Document the reaction in the patient's allergy record.
   ```
2. ```
   Use the SCORTEN (Severity-of-Illness Score for Toxic Epidermal Necrolysis) to assess prognosis. Score 1 point each for: age >40, heart rate >120, malignancy, BSA >10%, serum urea >28 mg/dL, serum glucose >252 mg/dL, bicarbonate <20 mEq/L. Higher scores indicate need for ICU transfer.
   ```

## 无效尝试

- **Switch to a different antibiotic from the same class (e.g., from amoxicillin to ampicillin)** — Cross-reactivity within the same antibiotic class is high; SJS can recur or worsen with a structurally similar drug. (90% 失败率)
- **Add antihistamines and corticosteroids while continuing the same antibiotic** — Corticosteroids are controversial in SJS and may increase infection risk; they do not halt the underlying immune reaction, and continuing the trigger drug is dangerous. (95% 失败率)
- **Reduce the antibiotic dose instead of stopping it** — SJS is an idiosyncratic immune reaction, not dose-dependent; dose reduction does not reduce the risk of progression to toxic epidermal necrolysis (TEN). (98% 失败率)